Smoking Tendency and Your Genetics

By the ExomeDNA Research Team | Last reviewed May 2026

Lifetime smoking is a composite behavioral phenotype that captures the overall pattern of tobacco use across an individual's lifespan — encompassing initiation, persistence, quantity smoked, and cessation history. Unlike snapshot measures, lifetime exposure integrates the full arc of smoking behavior. Research in behavioral genetics has established that lifetime smoking has a heritable component: twin studies estimate heritability in the range of 40–60 percent. Genome-wide studies have identified multiple loci associated with this composite measure, pointing to neurobiological pathways in reward, impulse regulation, and neurodevelopment that shape lifetime tobacco use.

What is Lifetime Smoking?

Lifetime smoking as a research phenotype typically combines information about whether a person has smoked, how much they smoked, and whether they have quit into a composite score that captures cumulative tobacco exposure. This integrative approach offers advantages over single-snapshot measures: it summarizes the full history of smoking behavior rather than capturing a point-in-time status, and is less sensitive to recent quit attempts that may not reflect lifetime patterns.

The genetic underpinnings of lifetime smoking overlap substantially with those of individual components — smoking initiation, cigarettes per day, and cessation success — while also reflecting broader behavioral factors including nicotine sensitivity, reward processing, and the interaction between biological predisposition and social environment.

Genetic research on lifetime smoking is methodologically complex because smoking behavior is deeply intertwined with social and socioeconomic factors. Educational attainment, income, and social context all correlate with both smoking rates and with genetic variants — raising important questions about whether identified genetic signals reflect direct smoking biology or are partly mediated through socioeconomic pathways. Pasman et al. (2022) specifically examined this interplay, studying how genetic risk for smoking relates to socioeconomic status and disentangling the two. (Pasman et al. 2022)[1]

The genetics behind Lifetime Smoking

Lifetime smoking has a polygenic genetic architecture involving multiple neurobiological pathways, with the strongest signals concentrated in genes related to reward processing, GABAergic neurodevelopment, and synaptic biology.

RASGRF2 (Ras protein-specific guanine nucleotide-releasing factor 2) is the top-ranked genetic signal for lifetime smoking in this analysis. RASGRF2 encodes a guanine nucleotide exchange factor that activates Ras-MAPK signaling in neurons — a pathway critical for synaptic plasticity and dopamine receptor function. RASGRF2 has appeared in genome-wide analyses of multiple substance use behaviors, consistent with a role in the neurobiological circuits underlying reward-seeking and addictive behaviors. (Pasman et al. 2022)[1]

ARID5B (AT-rich interaction domain 5B) is a transcription factor involved in epigenetic regulation and chromatin remodeling. ARID5B regulates gene expression in developing and mature neurons and has been associated with multiple behavioral traits in genome-wide research. Its connection to lifetime smoking may reflect broader epigenetic control of reward-related gene expression programs in the brain. (Pasman et al. 2022)[1]

BARHL2 (BarH-like homeobox 2) is a homeobox transcription factor required for the development and specification of inhibitory neuronal populations during brain development. BarH-like factors have established roles in defining the identity of neurons in reward-relevant brain circuits. Variants near BARHL2 appear in genome-wide analyses of smoking behavior, consistent with a contribution from early neurological development to the neural circuits underlying later behavioral predispositions. (Pasman et al. 2022)[1]

DLX6 (distal-less homeobox 6) encodes a transcription factor essential for the development of GABAergic interneurons — inhibitory neurons that modulate dopaminergic reward circuits and emotional processing. GABAergic interneuron function is central to the regulation of reward salience and impulse control, and disruption of these circuits has been implicated in vulnerability to addictive behaviors. Variants near DLX6 appear across multiple behavioral GWAS datasets, including those for smoking behavior. (Pasman et al. 2022)[1]

CADM2 (cell adhesion molecule 2) is a synaptic cell adhesion protein expressed in the brain that is involved in the formation and maintenance of synaptic connections. CADM2 has been one of the more replicated findings across behavioral GWAS datasets, appearing in association studies for BMI, risk-taking behavior, and multiple substance use traits including smoking — suggesting a shared neurobiological substrate across risk-related behaviors. (Pasman et al. 2022)[1]

BDNF (brain-derived neurotrophic factor) encodes a neurotrophin with critical roles in neuronal survival, plasticity, and the regulation of dopaminergic circuits. BDNF participates in the signaling system linking environmental experience to long-term neural circuit changes — a mechanism relevant to the persistence of smoking behavior and the difficulty of cessation in the context of nicotine neuroadaptation. (Pasman et al. 2022)[1]

Genome-wide analyses of lifetime smoking identify neurobiological signal clusters including dopamine-related genes (RASGRF2), GABAergic neurodevelopment (DLX6, BARHL2), and synaptic biology (CADM2) — reflecting the multi-pathway neurological basis of tobacco use behavior across the lifespan. (Pasman et al. 2022)^[1]

What the research says

Research base: Moderate. Lifetime smoking genetics is supported by replicated genome-wide findings, with the genetic architecture involving multiple neurological pathways. The moderate confidence tier reflects that individual loci have smaller effects than those in some physiological traits, and that the interplay between genetic predisposition and social environment adds interpretive complexity.

Pasman et al. (2022) examined genetic risk for lifetime smoking while explicitly investigating the interplay between genetic predisposition and socioeconomic status (SES). Their analysis recognized that genetic variants associated with smoking may partly operate through SES-related pathways — for example, variants affecting educational attainment might indirectly influence smoking rates through social and economic mechanisms rather than solely through direct neurobiological effects. This work advances understanding of whether identified genetic signals for smoking reflect direct biological effects on reward and addiction circuitry, or partly reflect indirect pathways through socioeconomic variables. (Pasman et al. 2022)[1]

The broader literature on smoking genetics — including studies of smoking initiation, cigarettes per day, and nicotine dependence — consistently identifies neurological and reward-pathway genes as central to the polygenic architecture of tobacco use behaviors.

Twin studies estimate the heritability of smoking behaviors at 40–60 percent. Genome-wide research increasingly identifies neurological pathways — including dopamine signaling, GABAergic circuitry, and synaptic biology — as the primary biological substrates of inherited smoking predisposition. (Pasman et al. 2022)^[1]

How Lifetime Smoking affects you

The ExomeDNA lifetime smoking result reflects polygenic associations identified in population studies. A higher score is associated with statistically greater lifetime smoking exposure compared to the population baseline — it does not forecast individual behavior or override the influence of social, environmental, and personal factors on smoking decisions.

Smoking behavior is among the most complex traits in behavioral genetics because it is simultaneously shaped by biological predisposition (nicotine sensitivity, reward processing, impulse regulation) and by powerful social, cultural, and economic forces. Genetic predisposition toward higher lifetime smoking exposure is not deterministic: the same genetic profile can manifest differently depending on the social environment, access to tobacco, peer influences, cessation support, and personal experience.

The result does not capture the health consequences of smoking themselves — it reflects biological predisposition to smoking behavior, a distinction worth keeping in mind when interpreting the score.

Working with your profile

What research suggests about factors that interact with lifetime smoking genetics

1. Social environment and policy context — Smoking initiation rates have dropped dramatically in countries with strong tobacco control policies, demonstrating that environmental factors substantially modify the expression of genetic predisposition. Social norms, product cost, availability, and peer networks all shape whether polygenic predisposition to smoking translates into behavior.
2. Stress and mental health — Nicotine has acute anxiolytic effects that may partly explain why genetic predisposition to smoking correlates with stress reactivity in some research. Addressing underlying stress through evidence-based strategies is relevant for individuals with higher predisposition.
3. Cessation support — Nicotine replacement therapy, varenicline, and behavioral support all show efficacy for cessation across genetic backgrounds. Genetic predisposition does not diminish the effectiveness of evidence-based cessation approaches.
4. Dopamine reward biology — The neurobiological mechanisms implicated in smoking genetics (dopamine signaling, reward processing) are the same targets of evidence-based cessation pharmacotherapy. Understanding the biological basis of smoking predisposition supports rather than discourages seeking structured cessation support.

Related traits and genes

Lifetime smoking shares genetic architecture with related behavioral traits in the ExomeDNA profile, reflecting overlapping neurobiological substrates.

Related Behavioral Traits:

• Smoking status — binary ever/never measure with partially distinct genetic architecture
• Smoking genetics without educational attainment — lifetime smoking phenotype with educational attainment removed from consideration
• Alcohol use behavior — overlapping dopamine reward pathway genetics

Cross-category related traits:

• ADHD genetic predisposition — shared impulsivity and dopamine signaling signals
• Stress response — shared neurobiological reward and stress pathways

RASGRF2 and CADM2 appear across multiple behavioral GWAS datasets, reflecting shared neurobiological substrates across substance use and risk-related behavioral traits.

Frequently asked questions

Does a high genetic score for lifetime smoking mean I will smoke? No. The score reflects statistical associations between genetic variants and lifetime smoking exposure measured in population studies. It captures a direction of polygenic predisposition compared to the population average — not a forecast of individual behavior. Social environment, personal choices, cessation support, and many other factors beyond genetic predisposition all shape smoking behavior.

Do smoking genetics differ from nicotine dependence genetics? There is substantial overlap. The genetic architecture of smoking behavior — initiation, persistence, cessation — overlaps with that of nicotine dependence, though each phenotype captures somewhat different aspects of tobacco use. Variants near reward pathway genes like RASGRF2 appear across multiple smoking-related phenotypes, suggesting shared underlying biology across these related traits.

Can genetics explain why some people find it harder to quit smoking? Research supports that heritable differences in nicotine metabolism, reward sensitivity, and stress reactivity all contribute to variation in cessation outcomes. Genes involved in dopamine signaling and stress response appear in smoking GWAS consistently. This suggests a biological basis for individual differences in cessation difficulty, though social support, cessation method, and motivation are equally significant factors.

Is the lifetime smoking result the same as a smoking status (ever/never) result? No. Lifetime smoking is a composite measure capturing the full history of tobacco use — initiation, quantity, and duration. Smoking status typically captures a binary (ever/never) or categorical measure. These phenotypes correlate but have partially distinct genetic architectures, with lifetime smoking more sensitive to genes affecting smoking persistence and quantity over time.

What is the connection between these smoking genes and broader health? This genetic result reflects predisposition to smoking behavior — not to the health consequences of smoking itself. The health risks associated with tobacco use are well-established across genetic backgrounds and operate through mechanisms distinct from the behavioral predisposition genetics captured here.

References

1. Pasman JA, Ip HF, van der Zee MD, et al. (2022). Genetic risk for smoking: Disentangling interplay between genes and socioeconomic status. Behavioral Genetics. PMID: 34855049.

--- Data sources: GWAS Catalog (NHGRI-EBI, accessed 2026-05-24) · Open Targets Platform (CC0 1.0, accessed 2026-05-24) · ClinVar (NCBI, accessed 2026-05-24)

This page is published by the ExomeDNA Research Team. Last reviewed: 2026-05-24.